Income Tax Expense (Benefit) of TherapeuticsMD, Inc. from 30 Sep 2011 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
TherapeuticsMD, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2011 to 31 Mar 2025.
  • TherapeuticsMD, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $32,000.
  • TherapeuticsMD, Inc. annual Income Tax Expense (Benefit) for 2024 was $31,000, a 28% increase from 2023.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

TherapeuticsMD, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $32,000 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q3 2022 $260,000 -$260,000 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $550,000 +$550,000 01 Apr 2022 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $0 $0 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q3 2021 $0 $0 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $0 $0 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $0 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q3 2011 $4,304 01 Jul 2011 30 Sep 2011 10-Q 07 Nov 2011 2011 Q3

TherapeuticsMD, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $31,000 +$12,000 +28% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $43,000 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.